Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Neurology and Therapy|June 23, 2023
Measuring Fatigue in Multiple Sclerosis: There may be Trouble AheadJames Close, Jo Vandercappellen, Miriam King, et al.Multiple Sclerosis and Related Disorders|June 16, 2023
Do clinical trials prepare to fail by failing to prepare? An examination of MS trials and recommendations for patient-reported outcome measure selectionJeremy Hobart, Tanuja Chitnis, Jiwon Oh, et al.Neurology and Therapy|June 10, 2022
Symptom Interconnectivity in Multiple Sclerosis: A Narrative Review of Potential Underlying Biological Disease ProcessesTanuja Chitnis, Jo Vandercappellen, Miriam King, et al.Eneurologicalsci|April 8, 2020
Measuring upper limb function in MS: Which existing patient reported outcomes are fit for purpose?James Close, Kathryn Baines, Laurie Burke, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 27, 2022
Patient-reported outcome measures in MS: Do development processes and patient involvement support valid quantification of clinically important variables?Trishna Bharadia, Jo Vandercappellen, Tanuja Chitnis, et al.The Spine Journal : Official Journal of the North American Spine Society|March 22, 2016
Measuring spinal surgical success: the proportion achieving acceptable symptoms: Keep it simple but not simplisticJeremy HobartCurrent Opinion in Neurology|November 26, 2002
Measuring disease impact in disabling neurological conditions: are patients' perspectives and scientific rigor compatible?Jeremy HobartCytokine & Growth Factor Reviews|November 30, 2010
The role of the CXC chemokines platelet factor-4 (CXCL4/PF-4) and its variant (CXCL4L1/PF-4var) in inflammation, angiogenesis and cancerJo Vandercappellen, Jo Van Damme, Sofie StruyfCancer Letters|June 27, 2008
The role of CXC chemokines and their receptors in cancerJo Vandercappellen, Jo Van Damme, Sofie StruyfJournal of Clinical Medicine|August 12, 2022
MSProDiscuss™ Clinical Decision Support Tool for Identifying Multiple Sclerosis ProgressionTjalf Ziemssen, Jo Vandercappellen, Valeria Jordan Mondragon, et al.Pageof 12